Feb 19, 2020 - Top Research Reports for Facebook, Netflix & NextEra Energy
Feb 19, 2020 - Sanofi (SNY) and J&J (JNJ) sign deals with BARDA, part of U.S. Department of Health and Human Services, for accelerated development of a vaccine for the newly found coronavirus.
Feb 17, 2020 - The switch will increase the availability of pain and allergy drugs from GlaxoSmithKline and Alcon.
Feb 11, 2020 - The FDA accepts Gilead's (GILD) BLA for its second CAR T cell therapy, KTE-X19.
Feb 07, 2020 - Merck (MRK), Bristol Myers (BMY), Sanofi (SNY), Glaxo (GSK) and Novo Nordisk (NVO) announce Q4 results.
Feb 06, 2020 - The workforce reduction is one of the moves being made to prepare for the pharmaceutical company's upcoming split into two entities.
Feb 06, 2020 - GSK earnings call for the period ending December 31, 2019.
Feb 05, 2020 - GlaxoSmithKline plc (NYSE:GSK) Q4 2019 Results Earnings Conference Call February 05, 2020, 9:00 am ET Company Participants Sarah Elton-Farr - Head of Global Investor Relations Emma Walmsley - Chief Ex
Feb 05, 2020 - The pharmaceutical giant's fourth-quarter 2019 earnings were disappointing, but there were things for investors to smile about in the new details on its upcoming spinoff.
Feb 05, 2020 - Gilead's (GILD) earnings fall short of estimates but sales beat the same in the fourth quarter of 2019.